semaglutide how to use Inject How to Give Yourself a
Description
Son zamanlarda medya gndemini ve yatrmclarn ilgisini en ok eken konulardan biri, "mucize zayflama ilalar" olarak nlenen GLP-1 agonistleri

Based on SURMOUNT-1 data analysis, tirzepatide decreased the 10-year estimated risk of ASCVD for obese or overweight patients

Real-world studies have shown heterogeneous findings

Patients should continue regular meals even if appetite is reduced, focusing on small, frequent portions of easily digestible foods

33 WattsNBBilezikianJPUsiskinKEdwardsRDesaiMLawGet al

Cooper et al
